MNA Analysis: 2016 Begins With Small List Highlighted By IVD Blockbuster
This article was originally published in Clinica
The first month of 2016 brought only 18 M&A deals, but among them was a major acquisition announcement that could have significant impact on the rapidly evolving in-vitro diagnostics space.
You may also be interested in...
2017 kicked off with 12 medtech M&A acquisitions in January, a decline from the 18 M&A deals recorded in the same month last year, and two fewer than the previous month.
The $800m sale of BTG Specialty Pharmaceuticals business to SERB leaves Boston Scientific with BTG’s successful interventional oncology and vascular products.
The FAST 01 feasibility trial is evaluating a modification to Varian’s ProBeam particle accelerator that enables ultra-high dose radiation to treat cancer.